Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
- 31 March 2009
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 112 (3), 537-542
- https://doi.org/10.1016/j.ygyno.2008.10.032
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Chemotherapy for high-risk early-stage endometrial cancerCurrent Opinion in Obstetrics and Gynecology, 2007
- Steroid receptor expressions in endometrial cancer: Clinical significance and epidemiological implicationCancer Letters, 2006
- Loss of MSH2 protein expression is a risk factor in early stage cervical cancerJournal of Clinical Pathology, 2006
- Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinomaThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcomaCancer, 2004
- A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinomaGynecologic Oncology, 2004
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004
- Clinical Implications of the Expression of Estrogen Receptor-α and -β in Primary and Metastatic Lesions of Uterine Endometrial CancersOncology, 2002
- Analysis of Estrogen Receptor ?? and ?? in Endometrial Carcinomas: Correlation with ER?? and Clinicopathologic Findings in 45 CasesInternational Journal of Gynecological Pathology, 2000
- Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of Stage I endometrial carcinomaCancer, 1999